Both in Pharmaceuticals
Annovis Bio vs Gain Therapeutics
Over the past year ANVS returned −46.2% and GANX returned −42.3%; their daily moves had a correlation of 0.20.
ANVS −46.2% GANX −42.3%Growth of $1, one year, split-adjusted
| Metric | ANVS | GANX |
|---|---|---|
| Price | $1.13 | $1.13 |
| Market cap | $48.2M | $49.3M |
| Today | +10.78% | −5.04% |
| 1 month | −3.4% | −34.3% |
| 6 months | −43.5% | −39.9% |
| Year to date | −67.3% | −64.9% |
| 1 year | −48.6% | −37.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $18.7M | $12.7M |
| Dividend yield | — | — |
| Volatility (60d) | 75.6% | 64.4% |
| Short % of float | 15.3% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).